News Tags :
drugs
cancer
epa
agreement
harvard university
therapy
pesticide

Egenix Licenses Harvard Anti-Cancer Platform

Egenix Licenses Harvard Anti-Cancer Platform

   Mr. Donald Fresne, Chairman and CEO of Egenix, Inc., announced today that the company has recently obtained from Harvard University a field-exclusive license under patent rights that cover certain technologies related to cancer therapy and prognostic testing.

Posted : Fri, Feb 01, 2008

Category : Science / Environment News

EPA settles with Target on pesticide violations

EPA settles with Target on pesticide violations

   >U.S. Environmental Protection Agency Region 5 has filed a consent agreement and final order with Target Corp., on alleged violations of federal rules on the labeling, distribution and sale of pesticide products.

Posted : Sun, Sep 30, 2007

Category : Science / Environment News
 
 
 
© TAUME.COM